Live feed07:30:21·780dSECFilingvia QuantisnowVirpax Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Changes in Control of Registrant, Leadership Update, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.VRPX· Virpax Pharmaceuticals Inc.Health CareOriginal source